Health Care & Life Sciences » Pharmaceuticals | AstraZeneca Pharma India Ltd.

AstraZeneca Pharma India Ltd. | Balance Sheet

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Cash & Short Term Investments
891
272
768
1,156
1,259
Total Accounts Receivable
862
1,489
891
603
587
Inventories
958
861
783
589
1,143
Other Current Assets
16
10
229
168
221
Total Current Assets
2,726
2,633
2,671
2,516
3,209
Net Property, Plant & Equipment
1,042
1,136
1,038
918
800
Total Investments and Advances
76
42
6
-
-
Long-Term Note Receivable
77
62
22
6
3
Other Assets
235
243
553
1,580
1,624
Total Assets
4,156
4,116
4,290
5,455
5,979
Accounts Payable
1,099
1,119
946
877
953
Income Tax Payable
8
8
79
54
54
Other Current Liabilities
1,329
1,472
1,316
973
1,063
Total Current Liabilities
2,435
2,598
2,340
1,903
2,070
Provision for Risks & Charges
-
-
117
23
67
Deferred Taxes
-
-
-
402
326
Other Liabilities
5
10
273
1,266
1,356
Total Liabilities
2,440
2,608
2,730
3,226
3,510
Common Equity (Total)
1,716
1,508
1,560
2,229
2,469
Total Shareholders' Equity
1,716
1,508
1,560
2,229
2,469
Total Equity
1,716
1,508
1,560
2,229
2,469
Liabilities & Shareholders' Equity
4,156
4,116
4,290
5,455
5,979

About AstraZeneca Pharma India

View Profile
Address
Block N1, 12th Floor
Bangalore Karnataka 560045
India
Employees -
Website http://www.astrazeneca.com/country-sites/india.html
Updated 09/14/2018
AstraZeneca Pharma India Ltd. engages in the manufacture, distribution, and marketing of pharmaceutical products and clinical trial services. It focuses in the areas of cardiovascular/metabolic disease, cancer and respiratory, inflammatory, and autoimmune disease. The company was founded on July 11, 1979 and is headquartered in Bangalore, India.